Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mwaba

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2019
Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan AfricaTao Chen, Lawrence Mwenge, Shabir Lakhi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness AnalysisTinevimbo Shiri, Angela Loyse, Lawrence Mwenge, et al.
The Lancet. Infectious Diseases|March 28, 2013
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control effortsBen J Marais, Knut Lönnroth, Stephen D Lawn, et al.
The Journal of Infectious Diseases|April 6, 2012
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needsAlimuddin Zumla, Ibrahim Abubakar, Mario Raviglione, et al.
The Lancet. Global Health|January 27, 2019
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysisGian Luca Di Tanna, Ali Raza Khaki, Grant Theron, et al.
The Lancet. Infectious Diseases|May 10, 2014
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trialSayoki G Mfinanga, Bruce J Kirenga, Duncan M Chanda, et al.
Open Forum Infectious Diseases|May 3, 2021
Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal MeningitisSíle F Molloy, Brad Ross, Cecilia Kanyama, et al.
The Lancet. Infectious Diseases|March 28, 2013
Drug-resistant tuberculosis: time for visionary political leadershipIbrahim Abubakar, Matteo Zignol, Dennis Falzon, et al.
The Journal of Infectious Diseases|April 13, 2012
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunitiesRuth McNerney, Markus Maeurer, Ibrahim Abubakar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 3, 2020
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the futureNathan Kapata, Chikwe Ihekweazu, Francine Ntoumi, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2019
Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan AfricaTao Chen, Lawrence Mwenge, Shabir Lakhi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness AnalysisTinevimbo Shiri, Angela Loyse, Lawrence Mwenge, et al.
The Lancet. Infectious Diseases|March 28, 2013
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control effortsBen J Marais, Knut Lönnroth, Stephen D Lawn, et al.
The Journal of Infectious Diseases|April 6, 2012
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needsAlimuddin Zumla, Ibrahim Abubakar, Mario Raviglione, et al.
The Lancet. Global Health|January 27, 2019
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysisGian Luca Di Tanna, Ali Raza Khaki, Grant Theron, et al.
The Lancet. Infectious Diseases|May 10, 2014
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trialSayoki G Mfinanga, Bruce J Kirenga, Duncan M Chanda, et al.
Open Forum Infectious Diseases|May 3, 2021
Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal MeningitisSíle F Molloy, Brad Ross, Cecilia Kanyama, et al.
The Lancet. Infectious Diseases|March 28, 2013
Drug-resistant tuberculosis: time for visionary political leadershipIbrahim Abubakar, Matteo Zignol, Dennis Falzon, et al.
The Journal of Infectious Diseases|April 13, 2012
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunitiesRuth McNerney, Markus Maeurer, Ibrahim Abubakar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 3, 2020
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the futureNathan Kapata, Chikwe Ihekweazu, Francine Ntoumi, et al.
Pageof 13